Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Parkinson's Disease

Free Subscription 15.12.2025 1 Ann Neurol 2 Exp Neurol 1 J Neural Transm (Vienna) 1 J Neurochem 1 J Neuropsychol 5 Lancet Neurol 4 Mov Disord 1 Nat Rev Neurol 1 Neurochem Res 2 Neurology 2 Neuroscience 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. ZHENG Y, Kou W, Yang G, Cai H, et al
   alpha-Synuclein Promotes the Expression and Release of Neurofilament Light Chain from Oligodendrocytes in a Murine Model: Implication for Multiple System Atrophy?
   Ann Neurol. 2025;98:1364-1379.
   PubMed         Abstract available
   
   

   
   Exp Neurol

2. LIU R, Wang R, Zhou X, Chu F, et al
   Noninvasive deep brain stimulation using theta-burst transcranial magnetic-acoustic coupling to modulate cortical rhythms in Parkinsonian mice.
   Exp Neurol. 2025;397:115592.
   PubMed         Abstract available
   
   
3. KILPELAINEN T, Yang R, Toivio J, Etelainen T, et al
   Novel PREP ligand, HUP-46, ameliorates behavioral deficits in an alpha-synuclein based Parkinson's disease model.
   Exp Neurol. 2025 Dec 10:115593. doi: 10.1016/j.expneurol.2025.115593.
   PubMed         Abstract available
   
   

   
   J Neural Transm (Vienna)

4. PHUENPATHOM W, Sringean J, Phumphid S, Rattanapitak N, et al
   From clutter to confidence: home environmental triggers and adaptive solutions for freezing of gait in Parkinson's disease.
   J Neural Transm (Vienna). 2025 Dec 6. doi: 10.1007/s00702-025-03077.
   PubMed         Abstract available
   
   

   
   J Neurochem

5. D'ANGLEMONT DE TASSIGNY X, Jimenez-Medina A, Lopez-Lopez I, Lopez-Barneo J, et al
   Phosphodiesterase Inhibition Increases Striatal GDNF and Protects Against Preclinical Parkinsonism.
   J Neurochem. 2025;169:e70321.
   PubMed         Abstract available
   
   

   
   J Neuropsychol

6. ROFES A, Janssen N, Rook J, de Ronde E, et al
   Animal fluency in people with Parkinson's disease: Item-based performance before and after deep brain stimulation surgery.
   J Neuropsychol. 2025 Dec 8. doi: 10.1111/jnp.70026.
   PubMed         Abstract available
   
   

   
   Lancet Neurol

7. DE CASTRO FONSECA M, Zanetti L, Fanourakis S, Sulzer DL, et al
   The gut microbiome, systemic inflammation, and autoimmunity in Parkinson's disease.
   Lancet Neurol. 2026;25:103-114.
   PubMed         Abstract available
   
   
8. KALIA LV
   Exploring immunomodulation with azathioprine in Parkinson's disease.
   Lancet Neurol. 2026;25:2-3.
   PubMed        
   
   
9. GREENLAND JC, Dresser K, Cutting E, Donegan R, et al
   Azathioprine for the treatment of early Parkinson's disease (AZA-PD): a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial.
   Lancet Neurol. 2026;25:39-49.
   PubMed         Abstract available
   
   
10. TAN EK
    The role of the exposome in Parkinson's disease.
    Lancet Neurol. 2026;25:5-7.
    PubMed        
    
    
11. MCNAMARA CG, Cryan JF
    Unravelling the role of the microbiome in Parkinson's disease.
    Lancet Neurol. 2026;25:7-8.
    PubMed        
    
    

    
    Mov Disord

12. LANG AE, Hauser RA, Kalia LV, Hersh B, et al
    LRRK2 as a Potential Disease-Modifying Target in Sporadic Parkinson's Disease.
    Mov Disord. 2025 Dec 12. doi: 10.1002/mds.70100.
    PubMed         Abstract available
    
    
13. DORRANCE S, Patel R, Stebbins GT, Adams J, et al
    It Is Personal: What People with Parkinson's Disease Say Matters Most for Quality of Life.
    Mov Disord. 2025 Dec 12. doi: 10.1002/mds.70134.
    PubMed         Abstract available
    
    
14. ZHANG Q, Li Y, Mao W, Zhang H, et al
    Deep Learning to Differentiate Parkinsonian Syndromes: From Proof of Concept to Clinical Trust.
    Mov Disord. 2025 Dec 4. doi: 10.1002/mds.70139.
    PubMed        
    
    
15. ZOLFAGHARI S, Kouchache T, Delva A, Bouhadoun S, et al
    Delayed Disease Onset Report in UK Biobank: Implications for Prodromal Studies in Parkinson's Disease.
    Mov Disord. 2025 Dec 4. doi: 10.1002/mds.70147.
    PubMed         Abstract available
    
    

    
    Nat Rev Neurol

16. WOOD H
    alpha-Synuclein signatures mark Parkinson disease subtypes.
    Nat Rev Neurol. 2025 Dec 8. doi: 10.1038/s41582-025-01176.
    PubMed        
    
    

    
    Neurochem Res

17. ZHOU H, Fan H, Bian H, Zou Y, et al
    PRMT5 Aggravates Parkinson's Disease Progression Through the Inhibition of Neuronal Autophagy Through DKK1.
    Neurochem Res. 2025;51:12.
    PubMed         Abstract available
    
    

    
    Neurology

18. LI CH, Fan SP, Chen PS, Chang YY, et al
    Plasma pTau217 and Neurofilament Light Chain as Differentiative Markers for Progressive Supranuclear Palsy From Parkinson Disease.
    Neurology. 2026;106:e214406.
    PubMed         Abstract available
    
    
19. CONTI M, Mascioli D, Simonetta C, Ferrari V, et al
    Clinical, Biological, and Functional Connectivity Profile of Patients With De Novo Parkinson Disease Who Are APOE epsilon4 Carriers.
    Neurology. 2026;106:e214449.
    PubMed         Abstract available
    
    

    
    Neuroscience

20. MOHAMED YA, Ahmed Nadeem AA, Ismail LM, Ghallab YK, et al
    Genetic predispositions and nutritional strategies: a review of nutrigenomics in Parkinson's disease.
    Neuroscience. 2025 Dec 9:S0306-4522(25)01160.
    PubMed         Abstract available
    
    
21. SARKAR S, Podder S
    Profiling the Braak progression in Parkinson's disease: a transcriptomics and ML driven identification of progressive biomarker and prognostic ceRNA signature.
    Neuroscience. 2025;593:41-55.
    PubMed         Abstract available
    
    

    
    PLoS One

22. BJORKDAHL A, Fristedt S, Filipowicz K, Bergman P, et al
    A small-scale study on dancing for people living with Parkinson's disease.
    PLoS One. 2025;20:e0335433.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.